INSIGHTS ON LIQUID DOSE MANUFACTURING

• Benefits Of Isolator Technology In Fill-Finish

  Isolator technology enhances sterility assurance, reduces contamination risk, improves operator safety, and supports regulatory compliance, making it essential for modern aseptic fill-finish operations.

• Why Spray Drying Is Gaining Attention

  Facing patent cliffs, pharma companies can leverage spray drying to reformulate complex biologics, enabling non-invasive delivery, boosting patient convenience, and securing new patents.

• Enhancing Biopharmaceutical Production Through Advanced Mixing

  Eliminate particulate contamination and product degradation in downstream bioprocessing. Learn how frictionless, levitating impeller technology ensures low-shear mixing and high yields.

• Scaling A Sterile Fill-Finish Program 4x Without Adding Complexity

  Scaling sterile fill-finish operations requires balancing tight clinical timelines with flexibility. Single-use formulation systems eliminate major capital costs, reduce cleaning burdens, and speed turnarounds without sacrificing product quality.

• Pioneering Precision In Pharma And Radiopharma Solutions

  5/21/2025

  Discover a company that delivers innovative pharmaceutical production solutions and specializes in Radiopharmaceuticals, Cell and Gene Therapy, and traditional drugs with precision-engineered, integrated systems.

• Enhancing Automated Environmental Monitoring In Gloveless Isolators

  1/7/2026

  Explore how automation and robotic-friendly solutions are transforming fill-and-finish operations and gain insights into gloveless processes, EM testing challenges, and collaborative innovations.

• Extractables, Leachables, And Risk: Ensuring Safety In Pharma Manufacturing

  9/8/2025

  This session is designed for teams developing new products, optimizing processes, or preparing regulatory submissions, and will provide practical tools for a better approach to E&L management.

• Reading Between The Lines: How To Evaluate Decontamination Cycle Time Claims

  8/19/2026

  Comparing isolator decontamination cycle times requires evaluating key variables like aeration endpoints and load patterns to build accurate capacity models and avoid costly delays.

• Minimizing Particulate Risk

  5/13/2026

  While visible particles often draw immediate attention, visual inspection alone is insufficient, as subvisible particulate matter can pose equally significant risks to patient safety.